Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung ...

New clinical evidence indicates that a widely used supplement may alter gut microbes involved in vitamin D biology and ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit Looks Back at Pancreatic Cancer in 2025: A Year of Progress, ...

Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its ...

Chronic circadian disruption — such as night-shift work, irregular schedules, or frequent jet lag — accelerates the development and spread of aggressive breast cancer.

A study by the Mildred Scheel Early Career Center group led by Dr. Mohamed Elgendy at the TUD Faculty of Medicine provides ...

Researchers at Karolinska Institutet have identified small molecules capable of influencing a hard-to-target receptor family ...

With enrollment completed and encouraging immune response and safety data observed in the Phase 1 trial, Anixa plans to advance the vaccine into a Phase 2 clinical trial and has assumed full ...

Starton Holdings filed for an initial public offering, as it works to develop a treatment for blood cancers. The clinical-stage biotechnology company plans to offer about 6.7 million shares priced at ...